| Literature DB >> 27965830 |
Adrian White1, Liz Tough1, Vicky Eyre2, Jane Vickery2, Anthea Asprey3, Cath Quinn1, Fiona Warren3, Colin Pritchard4, Nadine E Foster5, Rod S Taylor3, Martin Underwood6, Paul Dieppe3.
Abstract
BACKGROUND: Evidence suggests acupuncture may be effective for treating the symptoms of knee osteoarthritis. Offering this in a group setting may offer cost savings. The aim of this study was to establish the feasibility of a definitive trial to assess the clinical and cost-effectiveness of Western medical acupuncture given in groups, or given individually, for adults with severe knee pain attributable to osteoarthritis.Entities:
Keywords: Acupuncture; Healthcare delivery; Knee osteoarthritis; Pilot project; Primary health care; Randomised controlled trial
Year: 2016 PMID: 27965830 PMCID: PMC5153913 DOI: 10.1186/s40814-016-0051-5
Source DB: PubMed Journal: Pilot Feasibility Stud ISSN: 2055-5784
Fig. 1Study flow diagram
Baseline characteristics of the three arms
| ‘group’ ( | ‘individual’ ( | ‘standard’ ( | |
|---|---|---|---|
| Male, | 10 (50) | 12 (60) | 10 (50) |
| Age in years (mean, SD) | 64.7 (7.7) | 65.1 (9.9) | 64.9 (10.8) |
| BMI (mean, SD) | 32.0 (8.2) | 31.7 (5.1) | 31.7 (5.3) |
| Main activity, | |||
| Employed | 7 (35) | 7 (35) | 9 (45) |
| Housework | 0 (0) | 0 (0) | 1 (5) |
| Retired | 13 (65) | 12 (60) | 9 (45) |
| Other | 0 (0) | 1 (0.5) | 1 (5) |
| Pain elsewhere, | 12 (60) | 16 (80) | 16 (80) |
| Comorbidities, | |||
| 0 | 8 (40) | 10 (50) | 6 (30) |
| 1 | 6 (30) | 10 (50) | 11 (55) |
| 2 | 5 (25) | 0 (0) | 3 (15) |
| ≥3 | 1 (0.5) | 0 (0) | 0 (0) |
| Oral NSAIDs | |||
| Currently use | 2 (10) | 3 (15) | 5 (25) |
| Exercises: | |||
| Currently use | 10 (50) | 4 (20) | 8 (40) |
Values are n (%) except where stated. % is percent of group
‘group’ group acupuncture, ‘individual’ individual acupuncture, ‘standard’ standardised advice and exercise booklet only
WOMAC subscales and total
| Arm | ‘group’ | ‘individual’ | ‘standard’ |
|---|---|---|---|
| Mean (SD), | |||
| Pain pre | 9.5 (2.8), 20 | 10.9 (2.9), 20 | 9.3 (2.7), 20 |
| Pain 14w | 5.8 (4.3), 17 | 8.4 (2.8), 15 | 9.3 (3.9), 14 |
| Stiffness pre | 4.5 (1.4), 20 | 4.8 (1.7), 20 | 4.5 (1.2), 20 |
| Stiffness 14w | 3.1 (1.8), 17 | 3.4 (1.2), 15 | 4.0 (1.6), 14 |
| Function pre | 35.2 (9.6), 20 | 37.8 (8.4), 20 | 31.9 (9.3), 20 |
| Function 14w | 23.0 (16.1), 17 | 30.0 (10.1), 15 | 29.4 (11.5), 13 |
| Total pre | 49.1 (13.1), 20 | 53.4 (12.2), 20 | 45.6 (12.5), 20 |
| Total 14w | 31.9 (21.8), 17 | 41.8 (13.4), 15 | 42.8 (16.5), 13 |
Maximum scores for WOMAC are 20 (pain), 8 (stiffness), 68 (function), and 96 (total)
Pre baseline, 14w 14 week follow-up, ‘group’ group acupuncture, ‘individual’ individual acupuncture, ‘standard’ standardised care only
Other outcomes
| Arm | ‘group’ | ‘individual’ | ‘standard’ |
|---|---|---|---|
| Mean (SD), | |||
| EQ-5D pre | 0.545 (0.255), 19 | 0.480 (0.250), 20 | 0.555 (0.274), 19 |
| EQ-5D 14w | 0.639 (0.308), 17 | 0.660 (0.227), 14 | 0.560 (0.271), 13 |
| OKS pre | 22.8 (7.4), 20 | 22.4 (6.8), 20 | 24.2 (5.8), 20 |
| OKS 14w | 32.3 (11.1), 17 | 29.6 (7.7), 15 | 27.2 (7.7), 13 |
| Using NSAID daily, | |||
| pre | 11/20 (55 %) | 8/20 (40 %) | 10/20 (50 %) |
| 14w | 5/17 (29 %) | 4/14 (29 %) | 7/14 (50 %) |
| Troublesomea, | |||
| pre | 7/20 (35 %) | 9/20 (45 %) | 5/20 (25 %) |
| 14w | 3/17 (18 %) | 2/15 (13 %) | 3/14 (21 %) |
| Global changeb
| |||
| 14w | 7/17 (41 %) | 9/15 (60 %) | 2/14 (14 %) |
Pre baseline, 14w 14 week follow-up, ‘group’ group acupuncture, ‘individual’ individual acupuncture, ‘standard’ standardised care only, NSAID non-steroidal anti-inflammatory drug
aHighest two categories, extremely and very
bHighest two categories, much or moderately better